Ad is loading...
KAYS
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
UPC
Price
$0.14
Change
-$0.02 (-12.50%)
Updated
Nov 15 closing price
Ad is loading...

KAYS vs UPC

Header iconKAYS vs UPC Comparison
Open Charts KAYS vs UPCBanner chart's image
Kaya Holdings
Price$0.03
Change-$0.00 (-0.00%)
Volume$4.07K
CapitalizationN/A
Universe Pharmaceuticals
Price$0.14
Change-$0.02 (-12.50%)
Volume$2.16M
CapitalizationN/A
KAYS vs UPC Comparison Chart
Loading...
UPC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KAYS vs. UPC commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAYS is a Hold and UPC is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (KAYS: $0.03 vs. UPC: $0.14)
Brand notoriety: KAYS and UPC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KAYS: 78% vs. UPC: 58%
Market capitalization -- KAYS: $1.24M vs. UPC: $7.98M
KAYS [@Pharmaceuticals: Other] is valued at $1.24M. UPC’s [@Pharmaceuticals: Other] market capitalization is $7.98M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAYS’s FA Score shows that 1 FA rating(s) are green whileUPC’s FA Score has 0 green FA rating(s).

  • KAYS’s FA Score: 1 green, 4 red.
  • UPC’s FA Score: 0 green, 5 red.
According to our system of comparison, UPC is a better buy in the long-term than KAYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

UPC’s TA Score shows that 4 TA indicator(s) are bullish.

  • UPC’s TA Score: 4 bullish, 3 bearish.

Price Growth

KAYS (@Pharmaceuticals: Other) experienced а -6.47% price change this week, while UPC (@Pharmaceuticals: Other) price change was -44.17% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

KAYS is expected to report earnings on Apr 27, 2023.

UPC is expected to report earnings on Feb 10, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UPC($7.99M) has a higher market cap than KAYS($1.24M). UPC has higher P/E ratio than KAYS: UPC (3.00) vs KAYS (0.70). KAYS YTD gains are higher at: -23.990 vs. UPC (-93.000). KAYS has higher annual earnings (EBITDA): -1.42M vs. UPC (-7.29M). UPC has more cash in the bank: 5.71M vs. KAYS (30.5K). UPC has less debt than KAYS: UPC (3.94M) vs KAYS (7.66M). UPC has higher revenues than KAYS: UPC (40.1M) vs KAYS (545K).
KAYSUPCKAYS / UPC
Capitalization1.24M7.99M16%
EBITDA-1.42M-7.29M20%
Gain YTD-23.990-93.00026%
P/E Ratio0.703.0023%
Revenue545K40.1M1%
Total Cash30.5K5.71M1%
Total Debt7.66M3.94M195%
FUNDAMENTALS RATINGS
KAYS: Fundamental Ratings
KAYS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
UPC
RSI
ODDS (%)
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
UPC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BULIX18.480.27
+1.48%
American Century Utilities Inv
JVLIX26.69-0.24
-0.89%
JHancock Disciplined Value I
SMLKX23.65-0.22
-0.92%
Shelton S&P Smallcap Index K
SSMAX11.27-0.12
-1.05%
SEI Small/Mid Cap Equity A (SIIT)
TDEIX33.69-0.80
-2.32%
Transamerica US Growth I

KAYS and

Correlation & Price change

A.I.dvisor tells us that KAYS and KMDA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAYS and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAYS
1D Price
Change %
KAYS100%
N/A
KMDA - KAYS
21%
Poorly correlated
-0.85%
UPC - KAYS
8%
Poorly correlated
-13.20%
SHIEF - KAYS
4%
Poorly correlated
N/A
TRUFF - KAYS
4%
Poorly correlated
N/A
AYRWF - KAYS
3%
Poorly correlated
-1.28%
More